NCT02468570
Phenylketonuria
The below information is taken directly from public registry websites such as ClinicalTrials.gov, EuClinicalTrials.eu, ISRCTN.com, etc. and has not been edited.
A Phase 3 substudy to evaluate executive function in adults with phenylketonuria who are participating in the phase 3 Study, 165-302. Approximately 100 subjects, aged ≥ 18 to ≤ 70 years old, with PKU will be enrolled.
All
18 Years to 70 Years
No
Administration of CANTAB and Subject Global Assessment
Observational
9
2015-08-05
2020-06-04
Lexington, Kentucky, United States
Omaha, Nebraska, United States
Oklahoma City, Oklahoma, United States
Portland, Oregon, United States
*required fields
"*" indicates required fields